Table 2 MicroRNA therapeutics in fibrosis
Company | MicroRNA target | Stage |
|---|---|---|
Regulus Therapeutics | 21 (RG-012)/Antagomir | Phase 1 clinical trial Alport syndrome |
miRagen Therapeutics | 29 mimic | Pre-clinical development |
miRagen Therapeutics | 155a mimic | Pre-clinical |
Marina Biotech | 21 Antagomir | Pre-clinical |